Recurrent bacteremia caused by the Acinetobacter calcoaceticus- Acinetobacter baumannii complex

Journal of Clinical Microbiology

Volumn 50, Issue 9, 2012, Pages 2982-2986

  Lai, Chih Cheng ^a   Hsu, Han Lin ^b   Tan, Che Kim ^a   Tsai, Hsih Yeh ^c,d   Cheng, Aristine ^c,d   Liu, Chia Ying ^c   Huang, Yu Tsung ^c,d   Liao, Chun Hsing ^c   Sheng, Wang Huei ^d   Hsueh, Po Ren ^d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CIPROFLOXACIN; COLISTIN; DORIPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; RNA 23S; SULTAMICILLIN; TIGECYCLINE; TIMENTIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CATHETER INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; IMMUNOCOMPROMISED PATIENT; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; RECURRENT INFECTION; REINFECTION; RELAPSE; RETROSPECTIVE STUDY; SPECIES DIFFERENTIATION;

ACADEMIC MEDICAL CENTERS; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RECURRENCE; SEQUENCE ANALYSIS, DNA; SURVIVAL ANALYSIS; TAIWAN;

EID: 84865165895     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01194-12     Document Type: Article

References (23)

1. Aquirre-Avalos G, Mijangos-Mendez JC, Amaya-Tapia G. 2010. Acinetobacter baumannii bacteremia. Rev. Med. Inst. Mex. Sequro. Soc. 48:625-634.
2. Chang HC, et al. 2005. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J. Clin. Microbiol. 43:1632-1639.
3. Chuang YC, et al. 2011. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin. Infect. Dis. 52:352-360.
4. Cisneros JM, et al. 1996. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin. Infect. Dis. 22:1026-1032. (Pubitemid 26260606)
5. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement M100-S22. CLSI, Wayne, PA.
6. Esterly JS, et al. 2011. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections. Antimicrob. Agents Chemother. 55:4844-4849.
7. García-Garmendia JL, et al. 2001. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin. Infect. Dis. 33:939-946. (Pubitemid 32907093)
8. Hernández-Torres A, et al. 2010. Carbapenem and multidrug-resistant Acinetobacter baumannii colonization/infection: epidemiology and factors associated with infections. Med. Clin. (Barcelona) 135:389-396.
9. Kang CI, Chung DR, Peck KR, Song JH, Korean Network for Study on Infectious Diseases. 24 October 2011. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED. Am. J. Emerg. Med. doi.org/10.1016/j.ajem.2011.08.021.
10. Karah N, et al. 2011. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J. Antimicrob. Chemother. 66:738-744.
11. Ko WC, et al. 2008. Oligonucleotide-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates. J. Clin. Microbiol. 46:2052-2059.
12. Kuo LC, et al. 2007. Multidrug-resistant Acinetobacter baumannii bacteremia: clinical features, antimicrobial therapy and outcome. Clin. Microbiol. Infect. 13:196-198.
13. Lai CC, et al. 2011. Time to blood culture positivity as a predictor of drug resistance in Acinetobacter baumannii complex bacteremia. J. Infect. 63:96-98.
14. Lee YC, et al. 2011. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteremia: comparison of clinical features, prognostic factors and outcomes. J. Antimicrob. Chemother. 66:1839-1846.
15. Levin AS, Levy CE, Manrique AE, Medeiros EA, Costa SF. 2003. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int. J. Antimicrob. Agents 21:58-62. (Pubitemid 36043975)
16. Lim YM, Shin KS, Kim J. 2007. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J. Clin. Microbiol. 45:902-905. (Pubitemid 46427709)
17. Lin YC, et al. 2008. Application of a microsphere-based array of rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities. J. Clin. Microbiol. 46:612-617.
18. Maragakis LL, Perl TM. 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46:1254-1263. (Pubitemid 351589912)
19. Navon-Venezia S, Ben-Ami R, Carmeli Y. 2005. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr. Opin. Infect. Dis. 18:306-313. (Pubitemid 41017634)
20. Nemec A, et al. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly, Acinetobacter genomic species 13TU). Res. Microbiol. 162:393-404.
21. Seifert H, et al. 2005. Standardization and interlaboratory reproducibility assessment of pulse-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43:4328-4335. (Pubitemid 41298209)
22. Seifert H, Strate A, Pulverer G. 1995. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 74:340-349.
23. Yang S, Yoon HJ, Ki MR. 2011. Risk factors for mortality in Acinetobacter bacteremia. Braz. J. Infect. Dis. 15:501-502.